LEADER 02557nas  2200601-a 450 
001 996209298303316
005 20240226124422.0
011   $a2041-6008
024 7 $a10.4155/tde.10.16
035   $a(OCoLC)669147111
035   $a(CKB)2900000000000313
035   $a(CONSER)--2010243759
035   $a(NjHacI)992900000000000313
035   $a(EXLCZ)992900000000000313
100   $a20100823a20109999  ---            -
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cn$2rdamedia
183   $acr$2rdacarrier
200 00$aTherapeutic delivery
210   $aLondon $cFuture Science
210  1$aLondon :$cFuture Science,$d2010.
215   $a1 online resource $cillustrations (some colour)
300   $aRefereed/Peer-reviewed
311   $a2041-5990 
330   $aTransdermal drug delivery is an exciting and challenging area. There are numerous transdermal delivery systems currently available on the market. However, the transdermal market still remains limited to a narrow range of drugs. Further advances in transdermal delivery depend on the ability to overcome the challenges faced regarding the permeation and skin irritation of the drug molecules. Emergence of novel techniques for skin permeation enhancement and development of methods to lessen skin irritation would widen the transdermal market for hydrophilic compounds, macromolecules and conventional drugs for new therapeutic indications. As evident from the ongoing clinical trials of a wide variety of drugs for various clinical conditions, there is a great future for transdermal delivery of drugs.
531   $aTHER DELIV
531 10$aTher Deliv
606   $aTherapeutics$2fast$3(OCoLC)fst01149694
606   $aTherapeutics$vPeriodicals
606   $aDrug delivery systems$vPeriodicals
606   $aTechnology, Pharmaceutical
606   $aDrug Administration Routes
606   $aDrug Delivery Systems
606   $aDrug delivery systems$2fast$3(OCoLC)fst00898667
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  7$aTherapeutics.
615  0$aTherapeutics
615  0$aDrug delivery systems
615 22$aTechnology, Pharmaceutical.
615 22$aDrug Administration Routes.
615 12$aDrug Delivery Systems.
615  7$aDrug delivery systems.
676   $a615.6
700   $aPaudel$b Kalpana S.$01592771
801  0$bNjHacI
801  1$bNjHacl
906   $aJOURNAL
912   $a996209298303316
996   $aTherapeutic delivery$93911953
997   $aUNISA